809 — Global Bio-chem Technology Co Cashflow Statement
0.000.00%
- HK$584.95m
- HK$5.92bn
- HK$2.00bn
Annual cashflow statement for Global Bio-chem Technology Co, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -2,411 | -409 | -1,574 | 4,178 | 746 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 1,361 | -507 | 741 | -4,826 | -996 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 566 | 38.4 | 414 | 292 | 98.3 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -26.2 | -475 | -88 | -50.5 | 76 |
Capital Expenditures | -16.8 | -25.8 | -6.18 | -43.8 | 0 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 137 | 418 | 5.76 | 29.4 | -0.535 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 120 | 393 | -0.413 | -14.4 | -0.535 |
Financing Cash Flow Items | -95.3 | -58 | -12.1 | -53.2 | -71.1 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -25.9 | -48.7 | 110 | 113 | -76.1 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 73.8 | -132 | 20 | 46.5 | -2.78 |